
Centene Corporation CNC
$ 37.3
-0.67%
Annual report 2025
added 02-17-2026
Country |
|
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NYSESPB |
Shares |
493 M |
Market Cap[1] |
$ 18.4 B |
EBITDA (LTM) |
$ 3.57 B |
P/E (LTM) |
13.61 |
P/S (LTM) |
0.14 |
EPS (LTM) |
2.74 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 271.25 | -2.58 % | $ 71.5 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
CVS Health Corporation
CVS
|
$ 79.33 | 0.62 % | $ 101 B | NYSE,SPB | ||
|
Molina Healthcare
MOH
|
$ 145.88 | 0.57 % | $ 7.7 B | NYSE,SPB | ||
|
NovoCure Limited
NVCR
|
$ 10.58 | -3.82 % | $ 1.18 B | Nasdaq Global Select Market,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 304.33 | -0.84 % | $ 276 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 192.15 | -2.62 % | $ 23.1 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.